Cargando…

Immune Activation in Primary Human Immunodeficiency Virus: Influence of Duration of Infection, Treatment, and Substance Use

BACKGROUND: Primary human immunodeficiency virus (HIV) is characterized by dynamic changes in viral load and innate and adaptive immune responses; it is unclear the extent to which time from acquisition to antiretroviral therapy (ART) initiation and substance use impact these immunologic changes. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gilada, Trupti, Schnittman, Samuel R, White, Edward, Mercader, Jacqueline, Wang, Yixin, Dasgupta, Sayan, Valdez, Rogelio, Pinto-Santini, Delia, Pasalar, Siavash, Sanchez, Jorge, Gonzales, Pedro, Lama, Javier R, Bender Ignacio, Rachel, Duerr, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124591/ https://www.ncbi.nlm.nih.gov/pubmed/35611350 http://dx.doi.org/10.1093/ofid/ofac155

Ejemplares similares

Dynamic immune markers predict HIV acquisition and augment associations with sociobehavioral factors for HIV exposure
por: Bender Ignacio, Rachel A., et al.
Publicado: (2022)

Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study
por: Massanella, Marta, et al.
Publicado: (2021)

Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus
por: Fujita, Ayako W, et al.
Publicado: (2022)

Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2023)

HIV pretreatment drug resistance among cisgender MSM and transgender women from Lima, Peru
por: Trebelcock, William L, et al.
Publicado: (2019)

Safety of oral naltrexone in HIV-positive men who have sex with men and transgender women with alcohol use disorder and initiating antiretroviral therapy
por: Gonzales, Pedro, et al.
Publicado: (2020)

Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus
por: Schnittman, Samuel R, et al.
Publicado: (2023)

Care Facilitation Advances Movement Along the Hepatitis C Care Continuum for Persons With Human Immunodeficiency Virus, Hepatitis C, and Substance Use: A Randomized Clinical Trial (CTN-0064)
por: Metsch, Lisa R, et al.
Publicado: (2021)

Protocol for evaluating mechanistic pathways associated with HIV acquisition via nested Least Absolute Shrinkage and Selective Operator analysis
por: Dasgupta, Sayan, et al.
Publicado: (2023)

Low Rates of Contraception Use in Women With Human Immunodeficiency Virus
por: Bhatta, Manasa, et al.
Publicado: (2022)

Advanced Human Immunodeficiency Virus Disease at Diagnosis in Mozambique and Swaziland
por: Kujawski, Stephanie A, et al.
Publicado: (2017)

Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and Outcomes
por: Pastick, Katelyn A, et al.
Publicado: (2019)

Histoplasmosis in Patients With Cell-Mediated Immunodeficiency: Human Immunodeficiency Virus Infection, Organ Transplantation, and Tumor Necrosis Factor-α Inhibition
por: Luckett, Keith, et al.
Publicado: (2014)

Lung Function in Women With and Without Human Immunodeficiency Virus
por: Wang, Richard J, et al.
Publicado: (2022)

Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings
por: Gupta, Amita, et al.
Publicado: (2022)

Shedding of Hepatitis C Virus in Semen of Human Immunodeficiency Virus-Infected Men
por: Turner, Samuel S., et al.
Publicado: (2016)

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort
por: Balagopal, Ashwin, et al.
Publicado: (2016)

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees
por: Oganezova, Karina, et al.
Publicado: (2020)

Acute Kidney Injury and Urinary Biomarkers in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis
por: Schutz, Charlotte, et al.
Publicado: (2017)

Cytomegalovirus Retinitis Screening and Treatment in Human Immunodeficiency Virus Patients in Malawi: A Feasibility Study
por: Ocieczek, Paulina, et al.
Publicado: (2019)

Rectal Microbiome Alterations Associated With Oral Human Immunodeficiency Virus Pre-Exposure Prophylaxis
por: Fulcher, Jennifer A, et al.
Publicado: (2019)

Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus
por: Hall, Leangelo N., et al.
Publicado: (2017)

Differential Levels of Soluble Inflammatory Markers by Human Immunodeficiency Virus Controller Status and Demographics
por: Li, Jonathan Z., et al.
Publicado: (2014)

Visceral Adiposity Index as a Measure of Cardiovascular Disease in Persons With Human Immunodeficiency Virus
por: Thomas, Teressa S, et al.
Publicado: (2023)

Clinical and Metagenomic Characterization of Neurological Infections of People With Human Immunodeficiency Virus in the Peruvian Amazon
por: Steinberg, Hannah E, et al.
Publicado: (2023)

The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-Patients
por: Weijma, Robyn G. M., et al.
Publicado: (2015)

Compound Retention in Care and All-Cause Mortality Among Persons Living With Human Immunodeficiency Virus
por: Kay, Emma Sophia, et al.
Publicado: (2019)

Pediatric Kawasaki Disease and Adult Human Immunodeficiency Virus Kawasaki-Like Syndrome Are Likely the Same Malady
por: Johnson, Raymond M., et al.
Publicado: (2016)

Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality
por: Letang, Emilio, et al.
Publicado: (2015)

Emergence and Persistence of Letermovir-Resistant Cytomegalovirus in a Patient With Primary Immunodeficiency
por: Popping, Stephanie, et al.
Publicado: (2019)

Myocardial Fibrosis Among Antiretroviral Therapy-Treated Persons With Human Immunodeficiency Virus in South Africa
por: Shuldiner, Scott R, et al.
Publicado: (2020)

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection
por: Schnittman, Samuel R, et al.
Publicado: (2021)

Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South Africa
por: Paltiel, A. David, et al.
Publicado: (2017)

Clinical characteristics and symptom duration among outpatients with COVID-19
por: Lane, Alexandra, et al.
Publicado: (2022)

Colorectal Disorders in Acute Human Immunodeficiency Virus Infection: A Case Series
por: Panichsillapakit, Theppharit, et al.
Publicado: (2016)

Treatment Outcomes Among Older Human Immunodeficiency Virus-Infected Adults in Nigeria
por: Agaba, Patricia A., et al.
Publicado: (2017)

Parenting Desires Among Individuals Living With Human Immunodeficiency Virus in the United States
por: Cohn, Susan E, et al.
Publicado: (2018)

Risks of Opportunistic Infections in People With Human Immunodeficiency Virus With Cancers Treated With Chemotherapy
por: Makinson, Alain, et al.
Publicado: (2021)

Antiretroviral Refill Histories as a Predictor of Future Human Immunodeficiency Virus Viremia
por: Sokpa, Darryl, et al.
Publicado: (2022)

Understanding the Decline of Incident, Active Tuberculosis in People With Human Immunodeficiency Virus in Switzerland
por: Zeeb, Marius, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4jj3l645snlf1fc522u63fc63k